ESTIMATION OF ELETRIPTAN HYDROBROMIDE IN ORAL FILM DOSAGE FORM BY RP-HPLC

Abstract

A simple, precise, rapid and accurate RP-HPLC method was developed for the percentage drug release estimation of Eletriptan Hydrobromide in oral film dosage form. Eletriptan Hydrobromide is used to treat severe migraine headaches and it’s associated to nausea and sensitivity to light. Eletriptan Hydrobromide oral films were prepared by solvent casting method. It is available in market as conventional tablets (Relpax). An Xterra RP18 (150 × 4.6 with 5 microns particle size) and the mobile phase, consisting of KH2PO4 and triethylamine in water adjusting the pH-7.0 with o-phosphoric acid: acetonitrile in ratio of 98:2 v/v & acetonitrile: methanol HPLC Grade (80:20 v/v) was used as mobile phase in isocratic mode. The flow rate was 1.0 mL/min and the effluents were monitored at 225 nm. The retention time was 7.0 minutes and the detector response was linear in the concentration of 6.60-99.02µg/mL for Eletriptan Hydrobromide. The respective linear regression equation being Y = 11447 X + 5508 for Eletriptan Hydrobromide. The Limit of Detection (LOD) and Limit of Quantification (LOQ) were not applicable for dissolution parameter. The method was validated by determining its accuracy, precision, linearity and system suitability. The results of the study showed that the proposed RP-HPLC method is simple, rapid, precise, linear and accurate, which is useful for the routine estimation of percentage drug release of Eletriptan Hydrobromide in oral film dosage form.

Authors and Affiliations

Pavan Kumar Kothapuvari, Swati Rawat, Darna Bhikshapathi

Keywords

Related Articles

COMPATIBILITY STUDIES OF ATORVASTATIN CALCIUM WITH SELECTED EXCIPIENTS BY MEANS OF THERMAL AND FT-IR SPECTROSCOPIC METHODS FOR THE DEVELOPMENT OF IMMEDIATE RELEASE TABLET

The objectives of present investigation is to evaluate the compatibility of Atorvastatin calcium with immediate release excipients and to optimize the tablet which release is best comparable with innovator product by var...

FORMULATION AND EVALUATION OF NASAL NIOSOMAL IN SITU GELS OF LORATADINE

Loratadine is an antihistaminic drug, used in the treatment of allergic inflammation. Poor bioavailability of the drug from conventional dosage forms is especially attributable to mucociliary clearance and transient resi...

CHROMATOGRAPHIC FINGERPRINT ANALYSIS OF IXORA COCCINEA METHANOLIC FLOWER EXTRACT

Ixora coccinea (R.) belonging to the Rubiaceae family is an ornamental plant claimed for the management of oral cancer and one of ingredients in curing different ailments. The present investigation was carried out to det...

ANTIDIABETIC ACTIVITY OF EXTRACTS OF PITHECELLOBIUM DULCE BENTH LEAVES IN ALLOXAN INDUCED DIABETIC RATS

The objective of the present study was to study effect of Pithecellobium dulce Benth (P. dulce) leaves in alloxan induced diabetic rats. The P. dulce leaves were extracted by maceration and soxhelation method by using wa...

PREPARATION AND EVALUATION OF TASTE MASKED QUICK DISSOLVING FILM OF LORNOXICAM

Rheumatoid arthritis is the chronic painful disease of joint destruction and functional disability needing immediate action with patient compliance. Pain relieving Quick dissolving film (QDF) will be an accurate patient...

Download PDF file
  • EP ID EP625103
  • DOI -
  • Views 94
  • Downloads 0

How To Cite

Pavan Kumar Kothapuvari, Swati Rawat, Darna Bhikshapathi (2015). ESTIMATION OF ELETRIPTAN HYDROBROMIDE IN ORAL FILM DOSAGE FORM BY RP-HPLC. International Journal of Pharmaceutical Sciences and Drug Research, 7(6), 484-488. https://europub.co.uk/articles/-A-625103